Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ramskogler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Wiener Medizinische Wochenschrift (1946)|July 14, 2001
[Society-research-diagnosis: have classification problems in psychiatry been overcome at the beginning of the new millennium?]B Semler, N Benda, K Ramskogler, et al.
Wiener Medizinische Wochenschrift (1946)|August 23, 2001
[Diagnosis and differential diagnosis of consciousness disorders from the psychiatric viewpoint]B Semler, N Benda, K Ramskogler, et al.
Wiener Medizinische Wochenschrift (1946)|July 14, 2001
[Management of hallucinating patients]K Ramskogler, B Semler, K Gutierrez, et al.
Journal of Biomedical Science|February 15, 2001
Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trialsH Walter, K Ramskogler, B Semler, et al.
Wiener Klinische Wochenschrift|November 22, 2001
[Craving for alcohol and prevention of relapse]I Hertling, K Ramskogler, A Riegler, et al.
Archives of Women'S Mental Health|November 25, 2003
Gender-specific differences in alcoholism: implications for treatmentH Walter, K Gutierrez, K Ramskogler, et al.
Wiener Klinische Wochenschrift|July 4, 2001
[Possible interaction between ethanol and drugs and their significance for drug therapy in the elderly]K Ramskogler, I Hertling, A Riegler, et al.
Journal of Biomedical Science|February 15, 2001
The European acamprosate trials: conclusions for research and therapyO M Lesch, A Riegler, K Gutierrez, et al.
Alcohol (Fayetteville, N.Y.)|February 13, 2002
Sensitivity and specificity of carbohydrate-deficient transferrin in drinking experiments and different patientsH Walter, I Hertling, N Benda, et al.
Neuropsychobiology|February 28, 2003
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patientsI Hertling, M Philipp, A Dvorak, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Wiener Medizinische Wochenschrift (1946)|July 14, 2001
[Society-research-diagnosis: have classification problems in psychiatry been overcome at the beginning of the new millennium?]B Semler, N Benda, K Ramskogler, et al.
Wiener Medizinische Wochenschrift (1946)|August 23, 2001
[Diagnosis and differential diagnosis of consciousness disorders from the psychiatric viewpoint]B Semler, N Benda, K Ramskogler, et al.
Wiener Medizinische Wochenschrift (1946)|July 14, 2001
[Management of hallucinating patients]K Ramskogler, B Semler, K Gutierrez, et al.
Journal of Biomedical Science|February 15, 2001
Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trialsH Walter, K Ramskogler, B Semler, et al.
Wiener Klinische Wochenschrift|November 22, 2001
[Craving for alcohol and prevention of relapse]I Hertling, K Ramskogler, A Riegler, et al.
Archives of Women'S Mental Health|November 25, 2003
Gender-specific differences in alcoholism: implications for treatmentH Walter, K Gutierrez, K Ramskogler, et al.
Wiener Klinische Wochenschrift|July 4, 2001
[Possible interaction between ethanol and drugs and their significance for drug therapy in the elderly]K Ramskogler, I Hertling, A Riegler, et al.
Journal of Biomedical Science|February 15, 2001
The European acamprosate trials: conclusions for research and therapyO M Lesch, A Riegler, K Gutierrez, et al.
Alcohol (Fayetteville, N.Y.)|February 13, 2002
Sensitivity and specificity of carbohydrate-deficient transferrin in drinking experiments and different patientsH Walter, I Hertling, N Benda, et al.
Neuropsychobiology|February 28, 2003
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patientsI Hertling, M Philipp, A Dvorak, et al.
Pageof 1